GlassScriptPhysician profile
Jennifer Anne Morrison
NPI 1306951843
$3,662.33
in general payments reported to CMS, 2019-2025
25 companies · $758 in 2025
The $758 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $302 · 2021: $370 · 2022: $714 · 2023: $328 · 2024: $868 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,954.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $838.46 | 2020-2025 | Clareon, Rocklatan, Argos |
| Bausch & Lomb Americas INC. | $356.64 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $297.21 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $286.25 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $203.69 | 2019-2025 | Tecnis Iol |
| Abbvie INC. | $183.57 | 2023-2025 | |
| Horizon Therapeutics Plc | $170.68 | 2022 | |
| Allergan, INC. | $141.99 | 2020-2022 | |
| Biotissue Holdings INC. | $136.48 | 2022-2024 | |
| Ocular Therapeutix, INC. | $116.49 | 2022 | |
| Harrow Eye, LLC | $113.96 | 2023-2025 | Vevye, Ilevro, Iheezo |
| Kala Pharmaceuticals, INC. | $107.05 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $98.50 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $93.58 | 2019-2025 | |
| Rxsight INC | $91.56 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $87.66 | 2019 | |
| Glaukos Corporation | $76.86 | 2022-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite |
| Oyster Point Pharma, INC. | $55.41 | 2024-2025 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $51.23 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $41.22 | 2025 | Purified Cortrophin Gel |
| Sight Sciences, INC. | $36.07 | 2019-2025 | Omni Surgical System |
| Johnson & Johnson Vision Care, INC. | $30.89 | 2022 | |
| New World Medical,INC. | $18.08 | 2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Shire North American Group INC | $14.86 | 2019 | |
| Dompe US, INC. | $13.94 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.